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Abstract
Background: Thoracic aortic dissection (TAD) is the most common life-threatening disorder, and MMP-2 is involved
in TAD pathogenesis. Our purpose is to systematically evaluate the association of the MMP-2 gene with TAD risk in
Chinese Han population.
Methods: In our case–control study, we recruited 755 unrelated participants: 315 case participants with TAD and
440 controls. Twenty-two tag SNPs were selected from MMP-2 gene and were genotyped. Genotype data were
analyzed by logistic regression.
Results: Although we did not find any significant association for MMP-2 SNPs using single-marker analysis, we
identified many windows with haplotype frequencies significantly different between case participants and control
participants using a variable-sized sliding-window strategy. In particular, the most significant association was shown
by a 2-SNP window consisting of rs2241145 and rs9928731 (omnibus test: asymptotic Pasym = 7.48 × 10
−5 and
empirical Pemp = 0.001867). There were two protective haplotypes: CT (Pasym = 0.00303; odds ratio [OR], 0.403) and
GC (Pasym = 0.000976; OR, 0.448).
Conclusions: MMP-2 haplotypes are associated with genetic susceptibility to thoracic aortic dissection in Chinese
Han population.
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Background
Thoracic Aortic dissection (TAD) is a complex cardiovas-
cular disease with high morbidity and mortality [1]. It can
be affected by both genetic and environmental factors as
well as gene environment interaction [2]. It is believed that
hypertension is the main etiological risk factor in aortic
dissection development [3]. Clinical and genomic evidence
also shows that genetics plays an important role in the
development of thoracic aortic diseases [4, 5]. However,
the exact mechanism underlying thoracic aortic dissection
is still unclear [6, 7].
Inherited tissue connective diseases and atherosclerosis
are the main diseases related to TAD [8]. It is well known
that MMPs are deeply involved in the pathogenesis of
both inherited and not-inherited conditions [8]. For
example, MMP-12 in particular has not only been related
to dissection occurring in thoracic aorta of subjects who
were not affected by inherited diseases [9, 10], but also in
patients with Marfan syndrome [11]. Although in some
inherited TAD patients a specific pattern of MMPs/TIMPs
has been identified, it is still unclear in TAD patients with
atherosclerosis [8]. A widespread release of MMPs, such
as MMP-1, −2, −3, −8, −9,and −12 have been reported in
patients with aortic wall diseases and no genetic predis-
position [8]. In this field, MMP-2 has been studied inten-
sively [8, 12]. It has been shown that the expression level
of MMP-2 in the aortic walls was significantly higher in
the TAD than the normal group [7]. MMP-2 is one of
tightly regulated family of zinc dependent enzymes which
is important in extracellular matrix (ECM) degradation
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and remodeling [13]. It has been demonstrated that
MMP-2 is involved in pathogenesis of some tissue
remodeling-related diseases where the single nucleotide
polymorphisms (SNPs) were found significantly associated
with these diseases [14–16]. A haplotype with both
rs11644561 A and rs11643630 G in MMP-2 gene was
found to have a significantly reduced risk of breast cancer
(OR, 0.6; 95 % CI, 0.4–0.8) in a study of 6066 participants
carried out by Vanderbilt-Ingram Cancer Center [14].
Another several MMP-2 single nucleotide polymorphisms
(SNPs) have been identified to be associated with the
pathogenesis of some other tissue remodeling-related dis-
eases, such as systolic heart failure and stroke [15, 16].
Genetic evidence supporting a role for MMP-2 in tissue
remodeling-related diseases has come from these analyses.
Aortic dissection is also one of tissue remodeling-
related diseases [17]. The histological appearance of
aortic dissection is characterized by progressive degrad-
ation of extracellular matrix proteins by some proteo-
lytic enzymes, e.g. MMP-2 [18]. All these findings
strongly suggest that MMP-2 may play a specific role in
the development of TAD among the whole matrix
metalloproteinase family. Although a number of studies
have identified a link between the MMP-2 and the
development of thoracic aortic dissection [19, 20], none
have used a genetic approach to evaluate allelic vari-
ation in MMP-2 and odds of thoracic aortic dissection,
especially for not-inherited condition. So we aimed to
assess the association between MMP-2 gene and not-
inherited TAD.
The implementation of the International HapMap
Project has enabled rapid acquisition of data on com-
mon SNPs in an entire gene and exploration of disease-
associated genetic variants in that gene using a compre-
hensive approach [21]. In the current work, a tag SNP
approach was employed to probe common genetic vari-
ations in the MMP-2 gene as well as to construct
haplotype blocks where appropriate to determine the




We enrolled 315 patients with TAD referred to the
Cardiovascular Surgery Unit. The criterion for diagnos-
tics of TAD has been described previously [22]. Familial
TAD were excluded from the study. Familial TAD was de-
fined when one or more family members was affected by
TAD. Four hundred forty volunteers comparable for age
and ethnicity were used as controls. All controls were se-
lected from individuals who were admitted to Beijing An
Zhen Hospital for reasons other than aortic diseases,
mainly primary hypertension disease. All controls had a
negative history of vascular diseases. Patients and controls
were unrelated. All subjects underwent at least one type of
aortic imaging examination, including CT scan, MRI, echo-
cardiography, and angiography. Study participants were
interviewed in person by trained medical professionals
using a structured questionnaire. Detailed information on
demographic factors, prior disease history, tobacco and
alcohol use, diet, weight history, and family history of aortic
disease were collected for all participants. All protocols
involving human specimens were approved by the Institu-
tional Review Board at Beijing An Zhen Hospital. Each sub-
ject provided written informed consent.
Blood sample collection and genomic DNA extraction
Ethylenediamine tetraacetic acid (EDTA) anticoagulated
venous whole blood samples were collected from each par-
ticipant. Human genomic DNA was extracted using the
DNA Isolation Kit (Genomic DNA kit, Axygen Scientific
Inc, CA, USA) according to manufacturers’ instruction.
Laboratory staffs were blinded to the case–control status of
these subjects for all subsequent genotyping described.
SNP selection and genotyping
The tagger SNPs were selected by searching Han Chinese
data from the HapMap Project using the Tagger program in
Haploview 4.2 (Broad Institute, Cambridge, Massachusetts,
USA). Tag SNPs were identified to cover polymorphisms
with minimum minor allele frequency (MAF) of 0.05 or
greater in the MMP-2 gene and with an r2 of 0.80 or greater.
Selection of SNPs was completed in November 2009. In
addition to this tag SNP selection strategy, several high-
interest SNPs that have been reported in the literature were
also chosen. In this study, a total of 22 SNPs were identified.
Genotyping analysis of the SNPs was performed using
the MassARRAY platform (Sequenom, San Diego, CA,
USA). The chip-based matrix-assisted laser desorption
ionization time-of-flight (MALDI-TOF) mass spectrom-
etry technology is used in this procedure. Genotyping
quality was assessed by examination of duplicate
concordance and call rates for each SNP and a test for
compliance with Hardy-Weinberg equilibrium (HWE) in
controls.
Statistical analysis
Statistical analyses were performed on computer using
the statistical genetics software packages PLINK (version
1.07) and Haploview (version 4.2). Hardy–Weinberg
equilibrium (HWE) for genotypic distribution was deter-
mined by using the Pearson χ2 test for each group.
Group differences in demographic and baseline clinical
data were compared using Pearson χ2 test in case of
qualitative data and with t-tests for independent samples
in case of quantitative data. Comparisons of the distribu-
tions of the genotype, allele and haplotype frequencies
were performed using the Pearson χ2 test. Bonferroni
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corrections for multiple comparisons were performed. In
order to detect informative associations complementary
to our tagging SNP approach, haplotype analysis was
performed. Linkage disequilibrium (LD) blocks were con-
structed among the SNPs based on the default algorithm
of Gabriel et al. [23]. Moreover, the sliding window
approach was chosen to systematically analyze all possible
haplotypes. We performed an omnibus test of the haplo-
type association to jointly evaluate the significance of the
haplotype effects for sliding windows. Sliding windows
analyses assess the frequency of composite genotypes of a
fixed number of contiguous SNPs (shifting 1 SNP at a




Baseline and clinical characteristics of the subjects are
shown in Table 1. As expected, there were significantly
more male than female TAD patients included in this
study. We found statistical significant gender difference
in the occurrence of TAD. There were no significant dif-
ferences in the proportion of smoking habit, alcohol
abuse and other cardiovascular risk factors between
TAD cases and controls.
Genetic association analysis
The observed genotype distributions for all SNPs were
in Hardy-Weinberg equilibrium in the control group
and in the case group. In Table 2, the allele frequencies
and genotype distributions of all SNPs and the Pearson
χ2 analysis were reported. The strongest association was
observed at the rs11644561 coding variant, where the
frequency of the risk allele A was 13.02 % in TAD sub-
jects compared with 9.78 % in controls (P = 0.04813).
However, after correction for multiple testing, we found
no significant association between this SNP and the
TAD phenotype (data not shown). In summary, we did
not find a significant association with TAD for all 22
SNPs under study using single marker analysis.
Haplotype analysis was performed to further evaluate
the role of MMP-2 in TAD susceptibility. The LD struc-
ture was constructed with all SNPs genotyped (Fig. 1).
Four haplotype-blocks were defined based on the default
algorithm of Gabriel et al. [23] and used for subsequent
analyses. Overall, this four haplotype frequencies were
similar between cases and controls. No significant omni-
bus association was detected. Results from the haplotype-
based omnibus association analysis showed no evidence
for any association with risk of TAD (data not shown).
To further assess haplotype association, we conducted
a sliding-window analysis. There were 253 sliding win-
dows in MMP-2 gene. And there were 43 sliding win-
dows showing significant differences (Pemp <0.05) in
MMP-2 haplotype frequencies between case participants
and control participants with at least 1 significant win-
dow among sliding windows of a given size with at least
2 SNPs (Table 3). The importance of rs9928731 was
obvious because 39 of 43 “positive” windows contained
this SNP. The 2-SNP window rs2241145 and rs9928731
(Table 3) gave the most significant result: Pasym = 7.48 ×
10 −5. It remained significant after 15,000 permutations
correcting for multiple testing (Pemp = 0.001867). Of the
43 positive sliding windows, 38 windows carried these 2
SNPs. Our conditional logistic regression analysis indi-
cated that each of these 2 SNPs contributed inde-
pendent effects to the significant association between
this 2-SNP window and TAD: P = 1.71 × 10 −6 for
rs2241145, P = 1.54 × 10 −6 for rs9928731.
There were 2 protective haplotypes: CT (21; OR,
0.403) and GC (12; OR, 0.448), for which alleles 1 and 2
stand for the major and the minor alleles, respectively
(Table 4). For the CT haplotype, the frequencies were
about 2.1 % in the case group and more than 5.8 % in
the control group. For the GC haplotype, the frequencies
were about 3.5 % in the case group and 8.2 % in the con-
trol group. We further evaluated effects of genetic
models for the risk haplotype defined by the 2 SNPs
rs2241145-rs9928731. We found that the 2-SNP haplo-
type window rs2241145-rs9928731 in MMP-2 gene also
Table 1 Demographic and clinical characteristics of both TAD cases and healthy controls in a Chinese Han Population
Items Controls (n = 440) TAD patients (n = 315) p Value
Age 51.3 ± 14.4 51.3 ± 11.1 NS
Gender (male) n (%) 223 (50.7) 241 (76.5) <0.01
Smoking n (%) 191 (43.4) 153 (48.6) NS
Alcohol n (%) 92 (20.9) 75 (23.8) NS
Diabetes n (%) 65 (14.8) 53 (16.8) NS
Hypertension n (%) 367 (83.4) 258 (81.9) NS
Dyslipidaemia n (%) 258 (58.6) 198 (62.9) NS
CAD n (%) 73 (16.6) 68 (21.6) NS
Abbreviations: TAD thoracic aortic dissection, CADcoronary artery disease, NS not significant. Continuous data were tested using 2-tailed Student t test and categorical
data were tested using a Pearson χ2 test (with df = 1) for differences between TAD (patient) and control (normal) groups
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showed significant association with TAD in both additive
and dominant models (P = 0.002; OR, 0.6).
These results were based on analysis that did not take
cardiovascular risk factors as covariates into account. To
account for the interference of potential confounding
factors with our assessment of the relationship between
the haplotypes and TAD, we performed a multivariate
logistic regression analysis that was adjusted for the
covariates such as age, gender, hypertension, diabetes,
dyslipidemia, coronary artery diseases, alcohol and
smoking habit. When these cardiovascular risk factors
were included as covariates in the analysis, the conclu-
sion remained the same, with slight variation in the ac-
tual P values and ORs (data not shown).
Consistent with others’ observations [24, 25], there
were significantly more male TAD patients than female
TAD patients in this study. In order to minimize the
influence of gender difference and detect possible inter-
action between gender and haplotype frequencies, we
calculated association with TAD in gender-specific case–
control analysis. We verified the association of the 2-
SNP haplotype window rs2241145-rs9928731 in MMP-2
gene to the risk of TAD both in subsamples of males
and females: P = 0.0005 for males, P = 0.0088 for females.
(Table 5).
Discussion
A comprehensive way to examine gene is through a tag
SNP approach [26–28]. In the current study, by using a
SNP tagging approach, we identified and evaluated 22 tag
SNPs that efficiently encompasses most of the common
variants in the MMP-2 gene. To our knowledge, this is
the first study to use such a comprehensive approach to
investigate the roles of the MMP-2 gene in thoracic aortic
dissection. Our initial single marker analysis did not find
any significant difference in the genotypic distribution and
allele frequencies between the TAD patients and controls
for all 22 tag SNPs selected after Bonferroni correction.
(Table 1). Furthermore, since the haplotype-based associ-
ation method may be more powerful than the single locus
test for indirect LD association mapping [29–31], we ana-
lyzed haplotype association on these SNPs. Haplotype
blocks were defined according to Gabriel et al. in Haplo-
view software [23, 32]. We also adopted a variable-sized
Table 2 Allelic Association Tests for Single-Nucleotide Polymorphisms of the MMP-2 Gene
SNP Allelesa Genotype (1/11/22/2)a P (genotypic) Minor Allele Frequency P (allelic)
1/2 Cases Controls Cases Controls
rs11644561 A/G 8/66/241 7/72/361 0.1574 0.1302 0.0978 0.04813
rs11643630 G/T 51/148/113 81/226/131 0.1918 0.4006 0.4429 0.1026
rs243866 A/G 2/62/251 3/88/348 .09746 0.1048 0.1071 0.8863
rs243865 T/C 2/61/252 3/87/350 0.9744 0.1032 0.1057 0.8753
rs17859821 A/G 20/127/167 21/167/251 0.4407 0.2659 0.2380 0.2177
rs1030868 T/C 31/123/161 41/176/221 0.9337 0.2937 0.2945 0.9709
rs1477017 G/A 31/123/161 41/175/222 0.9514 0.2937 0.2934 0.9909
rs865094 G/A 24/129/162 43/180/215 0.5559 0.2810 0.3037 0.3402
rs17301608 T/C 49/143/123 71/211/154 0.5848 0.3825 0.4048 0.3836
rs1053605 T/C 7/76/232 4/101/335 0.3234 0.1429 0.1239 0.282
rs9302671 T/G 10/90/214 16/136/287 0.7480 0.1752 0.1913 0.4247
rs2241145 G/C 76/154/84 107/212/121 0.9667 0.4873 0.4841 0.9034
rs9928731 T/C 75/147/92 93/219/128 0.6140 0.4729 0.4602 0.6259
rs243849 T/C 13/98/204 14/123/294 0.7159 0.1968 0.1818 0.4618
rs243847 C/T 41/156/117 75/215/147 0.2625 0.3790 0.4176 0.139
rs2287074 A/G 30/132/150 43/176/215 0.8832 0.3077 0.3011 0.7863
rs1992116 T/C 30/134/151 43/176/220 1.7959 0.3079 0.2984 0.691
rs243839 G/A 47/157/110 69/217/151 0.9635 0.3997 0.4062 0.8001
rs11639960 G/A 32/126/157 39/185/210 0.7226 0.3016 0.3030 0.9533
rs243836 G/A 51/160/96 76/211/149 0.5814 0.4395 0.4163 0.3699
rs243835 C/T 44/150/120 54/224/161 0.6223 0.3790 0.3781 0.9733
rs7201 C/A 23/109/182 20/174/246 0.1517 0.2468 0.2462 0.8715
Abbreviations: SNP single nucleotide polymorphism
aAlleles 1 and 2 represent the major and minor alleles, respectively, and the genotype counts are shown in the order of 11, 12, and 22, respectively
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sliding-window strategy to evaluate the haplotypic effects
thoroughly. 43 of 253 possible sliding windows in the
MMP-2 gene showed significant differences in haplotype
frequencies between case participants and control partici-
pants (Table 2). The 2-SNP window rs2241145-rs9928731
showed the strongest association with risk of TAD and
the two constituent SNPs each contributed independent
effects to the haplotypic association. There were two pro-
tective haplotype defined by these 2 SNPs (Table 4).
MMP-2 has been considered as a target candidate
gene of genetic association studies for numerous human
diseases [33, 34]. As was mentioned in the introduction,
an association between MMP-2 SNPs and some tissue
remodeling-related diseases was recently reported in
several studies [14–16]. Several high-interest SNPs that
have been reported in these literature were also chosen.
However, we failed to find any significant difference
between the TAD cases and controls with these SNPs.
There may be several reasons for this discrepancy. First,
this might be explained by the fact that the etiology and
pathogenesis of TAD is different compared to the other
tissue remodeling-related diseases. For example, a
thrombus can lead to an embolic stroke [35], which is
different from TAD formation. Second, determining
what causes these diseases is complex. It is not a sur-
prise since it is common in complex diseases that the
significant association signals in one investigation appear
to be negative in other analyses. Behavioral and environ-
mental factors may be involved in the pathogenesis of
these diseases. Third, both different genetic backgrounds
between populations and minor diversities in sample
collection could contribute to the discrepancy between
the studies.
In the current study, we failed to find any significant
difference with our initial single marker analysis after
correction for multiple testing. However as we men-
tioned above, haplotype-based association method may
be more powerful than the single locus test for indirect
LD association mapping [29–31]. We verified that the
two constituent SNPs rs2241145-rs9928731 haplotype
window contributed to the risk of TAD. The inconsist-
ency of data observed between single marker analysis
and haplotype analysis might indicate that not one SNP
independently associated with risk of TAD, but the two
SNPs in combination. Also these two SNPs themselves
might not be the functional SNP. It was the gene region
Fig. 1 The reference single-nucleotide polymorphism (rs) locations and block structure of MMP-2 in samples from the study population. Pairwise
linkage disequilibrium relations between MMP-2 polymorphisms were reported using correlation coefficients (r2)
Liu et al. BMC Cardiovascular Disorders  (2016) 16:11 Page 5 of 8
related to this two constituent SNPs rs2241145-rs9928731
haplotype which carried functional aetiological variants.
For the 22 tag SNPs under our study, the most import-
ant one is rs9928731 as 39 of 43 “positive” sliding
windows contained this SNP. It was previously reported
to be associated with refractive error [36] and high my-
opia [37]. During myopia development, the sclera under-
goes active remodeling, which involves MMP-2 [38].
However it still has to be identified whether this
variation is the functional SNP causing these risk. This
variation is located in the intron of MMP-2 which is be-
tween the sixth and seventh exons. This region does not
contain any obvious regulatory elements which could
predict that rs9928731 is a functional variant. It is also
possible that the functional SNP is not rs9928731, but a
SNP in linkage disequilibrium with the true causal variants.
Clearly, further studies designed to study the mechanistic
Table 3 Summary of Exhaustive Haplotype Analyses Based on Omnibus Tests for Sliding Windows of All Possible Sizes Across
Separate Sets of Tag SNPs of MMP-2
No od SWs Most signifcant omnibus test
SNPs No SWa, No With Pemp < . SW Pasym
05 PEmp
1 22 0 rs11644561…rs11644561 0.0579 0.7502
2 21 1 rs2241145…rs9928731 7.48e-005 0.001867
3 20 2 rs9302674…rs9928731 0.00041 0.01153
4 19 3 rs243847…rs243839 0.000176 0.004666
5 18 5 rs243847…rs11639960 0.000223 0.0058
6 17 4 rs9302671…rs2287074 0.00031 0.008399
7 16 2 rs1093605…rs2287074 0.000739 0.022
8 15 2 rs17301608…rs2287074 0.000548 0.0158
9 14 4 rs1053605…rs243839 0.000678 0.0206
10 13 3 rs1053605…rs11639960 0.00039 0.01127
11 12 3 rs65094…rs243839 0.000817 0.02413
12 11 1 rs17859821…rs2287074 0.000834 0.02467
13 10 3 rs865094…rs243836 0.000767 0.02247
14 9 4 rs11643630…rs243847 0.000611 0.0182
15 8 9 rs11643630…rs2287074 0.000147 0.003866
16 7 1 rs11643630…rs19992116 0.000144 0.003866
17 6 0 rs11643630…rs243839 0.00221 0.0658
18 5 0 rs243866…rs243836 0.00395 0.1135
19 4 1 rs11643630…rs243836 0.000914 0.0276
20 3 1 rs11644561…rs243836 0.00129 0.04006
21 2 0 rs11644561…rs243835 0.00177 0.052
22 1 0 rs11644561…rs7201 0.00175 0.05173
Abbreviations: Pasym asymptotic P value; Pempempirical P value, SNP single nucleotide polymorphism, SW sliding window
Table 4 Data on 2-SNP haplotypes consisting of rs2241145 and
rs9928731
Frequency
Haplotype Cases Controls OR Pasym
GT(11) 0.4523 0.4019 1.23 0.0527
CT(21) 0.0205 0.0583 0.403 0.00303
GC(12) 0.0349 0.0822 0.448 0.000976
CC(22) 0.4923 0.4576 1.15 0.189
Abbreviations: OR odds ratio; Pasym asymptotic P value
Table 5 Data on 2-SNP Haplotypes Consisting of rs2241145 and
rs9928731 in the gender-stratified subsamples
Group Haplotype frequency Pasym
GT CT GC CC
Males
TAD cases 0.4538 0.0253 0.0337 0.4872 0.0005
Controls 0.4039 0.0515 0.0894 0.7552
Females
TAD cases 0.4481 0.0046 0.0384 0.5089 0.0088
Controls 0.3997 0.0656 0.0749 0.4599
Abbreviation: Pasymasymptotic P value
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function of this polymorphism and its clinical applications
are needed.
We should recognize the limitation of this study be-
cause of the gender difference between patients and con-
trols. In order to minimize the influence of gender
difference and detect possible interaction between gen-
der and SNP genotype status, we calculated associations
with TAD in gender-specific case–control analysis. We
also utilized multivariate logistic regression analysis to
adjust effects of clinical covariates including g`ender.
Based on the consistent significant findings of the 2-SNP
haplotype window from gender-stratified analysis and lo-
gistic regression analysis, we are confident that the risk
estimation we report is valid.
Conclusion
In conclusion, we have taken a tag SNP approach to assess
the role of common variation throughout the MMP-2
gene for an association with thoracic aortic dissection.
With a sliding-window analysis, we found that the MMP-
2 2-SNP window rs2241145-rs9928731 showed the most
significant association with TAD. Therefore, MMP-2 poly-
morphisms are likely to play an important role in the gen-
etic predisposition to TAD. These findings potentially may
have significant benefit for the individualized treatment of
TAD in the future.
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